{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:32:51Z","timestamp":1767713571035},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T00:00:00Z","timestamp":1276646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00228-010-0856-8","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T12:17:20Z","timestamp":1276604240000},"page":"937-945","source":"Crossref","is-referenced-by-count":19,"title":["Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital"],"prefix":"10.1007","volume":"66","author":[{"given":"Gloria","family":"Cereza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Agust\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Pedr\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Vallano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculada","family":"Dan\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Arnau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"key":"856_CR1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","volume":"165","author":"DK Wysowski","year":"2005","unstructured":"Wysowski DK, Swartz L (2005) Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002: the importance of reporting suspected reactions. Arch Intern Med 165:1363\u20131369","journal-title":"Arch Intern Med"},{"key":"856_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2125.2006.02860.x","volume":"63","author":"JK Aronson","year":"2007","unstructured":"Aronson JK (2007) Adverse drug reactions\u2014no farewell to harms. Br J Clin Pharmacol 63:131\u2013135","journal-title":"Br J Clin Pharmacol"},{"key":"856_CR3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2165\/00002018-200124130-00003","volume":"24","author":"PA Th\u00fcrmann","year":"2001","unstructured":"Th\u00fcrmann PA (2001) Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 24:961\u2013968","journal-title":"Drug Saf"},{"key":"856_CR4","first-page":"41","volume":"29","author":"MD Rawlins","year":"1995","unstructured":"Rawlins MD (1995) Pharmacovigilance; paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond 29:41\u201349","journal-title":"J R Coll Physicians Lond"},{"key":"856_CR5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2125.2005.02504.x","volume":"60","author":"A Vallano","year":"2005","unstructured":"Vallano A, Cereza G, Pedros C, Agusti A, Danes I, Aguilera C, Arnau JM (2005) Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 60:653\u2013658","journal-title":"Br J Clin Pharmacol"},{"key":"856_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2125.1997.05417.x","volume":"43","author":"Y Moride","year":"1997","unstructured":"Moride Y, Haramburu F, Requejo AA, Begaud B (1997) Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol 43:177\u2013181","journal-title":"Br J Clin Pharmacol"},{"key":"856_CR7","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jama.296.9.1086","volume":"296","author":"A Figueiras","year":"2006","unstructured":"Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ (2006) An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 296:1086\u20131093","journal-title":"JAMA"},{"key":"856_CR8","first-page":"244","volume":"29","author":"M Nazario","year":"1994","unstructured":"Nazario M, Feliu JF, Rivera GC (1994) Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience. Hosp Pharm 29:244\u2013250","journal-title":"Hosp Pharm"},{"key":"856_CR9","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.1990.03440130073028","volume":"263","author":"HD Scott","year":"1990","unstructured":"Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ Jr, Green M, Andrews LG, Faich GA (1990) Physician reporting of adverse drug reactions. Results of the Rhode Island adverse drug reaction reporting project. JAMA 263:1785\u20131788","journal-title":"JAMA"},{"key":"856_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/089719008900200407","volume":"2","author":"J Fincham","year":"1989","unstructured":"Fincham J (1989) A statewide program to stimulate reporting of adverse drug reactions. J Pharm Pract 2:239\u2013244","journal-title":"J Pharm Pract"},{"key":"856_CR11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2125.1997.00616.x","volume":"44","author":"P McGettigan","year":"1997","unstructured":"McGettigan P, Golden J, Conroy RM, Arthur N, Feely J (1997) Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 44:98\u2013100","journal-title":"Br J Clin Pharmacol"},{"key":"856_CR12","first-page":"1086","volume":"45","author":"BJ Kimelblatt","year":"1988","unstructured":"Kimelblatt BJ, Young SH, Heywood PM, Mandala AR, Gendelman S, Mehl B (1988) Improved reporting of adverse drug reactions. Am J Hosp Pharm 45:1086\u20131089","journal-title":"Am J Hosp Pharm"},{"key":"856_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00002018-200932010-00007","volume":"32","author":"C Pedr\u00f3s","year":"2009","unstructured":"Pedr\u00f3s C, Vallano A, Cereza G, Mendoza-Aran G, Agust\u00ed A, Aguilera C, Dan\u00e9s I, Vidal X, Arnau JM (2009) An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians. A time series analysis in Spain. Drug Saf 32:77\u201383","journal-title":"Drug Saf"},{"key":"856_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pds.2630040206","volume":"4","author":"I Maistrello","year":"1995","unstructured":"Maistrello I, Morgutti M, Maltempi M, Dantes M (1995) Adverse drug reactions in hospitalized patients: an operational procedure to improve reporting and investigate underreporting. Pharmacoepidemiol Drug Saf 4:101\u2013106","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"856_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0306-5251.2001.01454.x","volume":"52","author":"AR Cox","year":"2001","unstructured":"Cox AR, Anton C, Goh CHF, Easter M, Langford NJ, Ferner RE (2001) Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol 52:337\u2013339","journal-title":"Br J Clin Pharmacol"},{"key":"856_CR16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1345\/aph.1L130","volume":"42","author":"A Ortega","year":"2008","unstructured":"Ortega A, Aguinagalde A, Lacasa C, Aquerreta I, Fern\u00e1ndez-Ben\u00edtez M, Fern\u00e1ndez LM (2008) Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother 42:1491\u20131496","journal-title":"Ann Pharmacother"},{"key":"856_CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phrs.2006.05.003","volume":"54","author":"J Jose","year":"2006","unstructured":"Jose J, Rao PGM (2006) Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 54:226\u2013233","journal-title":"Pharmacol Res"},{"key":"856_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2125.2007.02993.x","volume":"65","author":"R Arulmani","year":"2007","unstructured":"Arulmani R, Rajendran SD, Suresh B (2007) Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 65:210\u2013216","journal-title":"Br J Clin Pharmacol"},{"key":"856_CR19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1742-7843.2008.00217.x","volume":"102","author":"S Baniasadi","year":"2008","unstructured":"Baniasadi S, Fahimi F, Shalviri G (2008) Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol 102:408\u2013411","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"856_CR20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bmj.315.7107.500","volume":"315","author":"R Edwards","year":"1997","unstructured":"Edwards R (1997) Adverse drug reactions: finding the needle in the haystack. Br Med J 315:500","journal-title":"Br Med J"},{"key":"856_CR21","unstructured":"Commission Directive 2000\/38\/EC of 5 June 2000 amending Chapter Va (Pharmacovigilance) of Council Directive 75\/319\/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products. Official Journal of the European Communities 10.6.2000: L139\/28-L139\/30. Available from http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2000:139:0028:0030:EN:PDF . Accessed 10 September 2009"},{"key":"856_CR22","first-page":"147","volume-title":"Principios de epidemiolog\u00eda del medicamento","author":"D Capell\u00e0","year":"1993","unstructured":"Capell\u00e0 D, Laporte J-R (1993) La notificaci\u00f3n espont\u00e1nea de reacciones adversas a medicamentos. In: Laporte J-R, Tognoni G (eds) Principios de epidemiolog\u00eda del medicamento, 2nd edn. Masson-Salvat, Barcelona, pp 147\u2013170","edition":"2"},{"key":"856_CR23","unstructured":"Spanish Agency of Medicines and Health Products. Product Information. Gelafundina\u00ae. https:\/\/sinaem4.agemed.es\/consaem\/especialidad.do?metodo=verFichaWordPdf&codigo=61627&formato=pdf&formulario=FICHAS . Accessed 10 September 2009"},{"key":"856_CR24","unstructured":"Spanish Agency of Medicines and Health Products. Informative note. Recommendations for the withdrawal of the treatment with Agreal\u00ae (Veralipride). http:\/\/www.agemed.es\/actividad\/alertas\/docs\/NI_2005-15_AGREAL.pdf . Accessed 10 September 2009"},{"key":"856_CR25","unstructured":"European Medicines Agency. Questions and answers on the recommendation to withdraw the marketing authorisation of veralipride. http:\/\/www.emea.europa.eu\/pdfs\/human\/referral\/agreal\/29946807en.pdf . Accessed 10 September 2009"},{"key":"856_CR26","unstructured":"European Medicines Agency. Xigris. Procedural steps taken and scientific information after the authorisation. Changes made after 01\/10\/2004. http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/xigris\/H-396-en8b.pdf . Accessed 10 September 2009"},{"key":"856_CR27","first-page":"16","volume":"13","author":"R Uppal","year":"2000","unstructured":"Uppal R, Jhaj R, Malhotra S (2000) Adverse drug reactions among inpatients in a north Indian referral hospital. Natl Med J India 13:16\u201318","journal-title":"Natl Med J India"},{"key":"856_CR28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2125.2006.02633.x","volume":"62","author":"S Lugardon","year":"2006","unstructured":"Lugardon S, Desboeuf K, Fernet P, Monstastruc J-L, Lapeyre-Mestre M (2006) Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. Br J Clin Pharmacol 62:225\u2013231","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0856-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-010-0856-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0856-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:52:08Z","timestamp":1558702328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-010-0856-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1007\/s00228-010-0856-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,16]]}}}